
Epigral Limited's Bank Facilities Rated by CRISIL; Long Term and Short Term Ratings Reaffirmed
Epigral Limited has received revised ratings from CRISIL Ratings for its bank facilities. The rating details, issued on July 13, 2026, confirm the standing of the company regarding its lending commitments.CRISIL assigned these updated ratings to a total bank loan facility amounting to Rs. 1050 Crore. The ratings cover both long-term and short-term aspects of the facilities.
The financial ratings issued by CRISIL Ratings are detailed below:
| Rating Category | Facilities Rated | Rating Status |
|---|---|---|
| Total Bank Loan Facilities | Rs. 1050 Crore | N/A |
| Long Term Rating | CRISIL AA/Stable (Reaffirmed) | |
| Short Term Rating | CRISIL A1+ (Reaffirmed) |
The ratings reaffirm Epigral Limited’s standing based on the assessment of its bank facilities by the credit rating agency.
EPIGRAL Stock Price Movement
Epigral Limited shares slipped by 1.56% on Tuesday, closing at ₹1048 after the equity shed ₹16.70 from its previous close. The stock traded through a volume of 67,074 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.